Yes. Three studies have been conducted on Qualia Senolytic. In the most recent clinical study, Qualia Senolytic significantly improved aspects of healthy function during aging, particularly joint comfort and performance compared to a placebo.

In a preclinical study screening 10 flavonoid polyphenols for senolytic activity using human and mouse fibroblasts, fisetin was identified as the most potent senolytic, surpassing the clinically studied compound quercetin. Several ongoing clinical studies by the Mayo Clinic are further assessing fisetin’s senolytic action in humans.

Take Qualia Senolytic with any meal that is most convenient for you. Each serving should be taken on two consecutive days (six capsules per day). Wait about four weeks before repeating. For best results, use monthly.

No, daily use is not recommended. Intermittent use—often referred to as a “hit and run” approach—is the most common method in clinical studies for supporting healthy aging. This is also how Qualia Senolytic was supplemented in its three studies.

Soybeans are a primary source of isoflavones, which have been studied for their potential role in managing senescent cells. The soy isoflavone daidzein was among the top four compounds identified for its structure and function in supporting senescent cell management. Qualia Senolytic includes a soybean seed extract standardized for 40% isoflavones to complement the overall formulation.

Yes. A double-blind, placebo-controlled clinical trial included 36 adults aged 35 to 79 with moderate difficulty in daily activities. Participants completed three two-day supplementation cycles over about one month. The study showed a statistically significant improvement in joint health and performance, with an average 68% reduction in joint discomfort.